Form 4 for BRTX BioRestorative Therapies, Inc.
Accepted 2022-06-03 00:00:00 ET · period of report 2022-06-01 · accession 0001567619-22-012250 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-03 | 2022-06-01 | BRTX | Broadrick Dale | 10% | P - Purchase | $4.46 | +9,213 | 277.5K | +3% | +$41.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-01 | P | A | 9,213 | $4.46 | 277,473 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $4.0659 to $4.62 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected. |